RSS
 

The Lack of EpiPen Competitors is the FDA’s Fault

25 Aug

“There‚Äôs a new bout of outrage over an expensive medicine or medical treatment. While the good in question changes each time, the blame always seems to fall on greedy corporation…”

Source: The Lack of EpiPen Competitors is the FDA’s Fault

 
Comments Off on The Lack of EpiPen Competitors is the FDA’s Fault

Posted in Federal Government, Innovation, Regulations

 

Comments are closed.